Answers are grounded in this paper and cite their sources.
Prenatal screening identifies potential health risks, highlighting the significance of early detection for congenital abnormalities.
Fetal exposure in utero to environmental factors and maternal factors can lead to epigenetic changes that have a lasting impact on metabolic programming in the developing organism. These changes may be either temporary or permanent and can have significant implications for the health of the individual later in life. In this context, prenatal screening is an essential component of prenatal care, providing valuable information about the health status of the developing fetus and allowing healthcare providers to identify potential health risks to both the mother and the baby. Various screening methods are available, including ultrasound scans, non-invasive prenatal testing (NIPT), and biochemical markers. During prenatal care, various conditions are screened for, including preterm birth, preeclampsia, diabetes, fetal growth restriction, chromosomal abnormalities, thrombophilia, infections, and thyroid disease. However, the most crucial screening test during pregnancy is for congenital abnormalities, which affect approximately 2% of newborns. While each screening method has its own advantages and limitations, combining multiple methods may improve the accuracy of detecting fetal abnormalities and provide a more comprehensive picture of fetal health.
No takes yet. Share an insight, caveat, or question.
Bohîlțea et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: